Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01592383
Title Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637-1470 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field